The upregulation of Osteopontin mediates acquired resistance to EGFR-TKI in NSCLC through Integrin/FAK signaling

Y. Fu (Suzhou, China), Y. Zhang (Suzhou, China), Z. Liu (Suzhou, China), J. Huang (Suzhou, China)

Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Session: Biological mechanisms of lung cancer
Session type: E-poster session
Number: 1762
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Fu (Suzhou, China), Y. Zhang (Suzhou, China), Z. Liu (Suzhou, China), J. Huang (Suzhou, China). The upregulation of Osteopontin mediates acquired resistance to EGFR-TKI in NSCLC through Integrin/FAK signaling. 1762

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: